Xtx Topco LTD Denali Therapeutics Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $921,253 - $1.35 Million	44,656 New	44,656 $921,000
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $5,466 - $7,055	208 Added 1.73%	12,231 $340,000
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $312,237 - $463,246	12,023 New	12,023 $369,000
Q2 2021 Aug 12, 2021	SELL	$50.3 - $78.44 $185,254 - $288,894	-3,683 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$53.8 - $81.53 $198,145 - $300,274	3,683 New	3,683 $210,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.